People: Exelixis Inc (EXEL.O)

EXEL.O on Nasdaq

4.61USD
3:14pm EDT
Price Change (% chg)

$0.12 (+2.56%)
Prev Close
$4.55
Open
$4.50
Day's High
$4.63
Day's Low
$4.50
Volume
643,052
Avg. Vol
1,413,425
52-wk High
$6.95
52-wk Low
$4.19

Search Stocks

Morrissey, Michael 

Brief Biography

Dr. Michael M. Morrissey, Ph.D., serves as President, Chief Executive Officer, Director of Exelixis, Inc., since July 15, 2010. Dr. Morrissey has held positions of increasing responsibility at Exelixis since he joined the company in February 2000, including serving as President of Research and Development from January 2007 until July 2010. From 1991 to 2000, Dr. Morrissey held several positions at Berlex Biosciences, last holding the position of Vice President, Discovery Research. He is the author of numerous scientific publications in medicinal chemistry and drug discovery and an inventor on 70 issued U.S. patents and 25 additional published U.S. patent applications. Dr. Morrissey holds a B.S. (Honors) in Chemistry from the University of Wisconsin and a Ph.D. in Chemistry from Harvard University.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
1,056,970 -- 2,287,910 3,344,880

Options Compensation

  Quantity Market Value
Excercisable 330,000 755,450.00
Unexercisable 375,000 193,500.00
Excercised 82,500 --
Name Fiscal Year Total

Stelios Papadopoulos

--

Michael Morrissey

3,344,880

Frank Karbe

1,368,970

Peter Lamb

--

Pamela Simonton

1,310,610

J. Scott Garland

1,273,040
As Of 27 Dec 2012
Search Stocks